公司资料
Alphatec Holdings, Inc. 股价、新闻与催化剂
- 股票代码:
- ATEC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
9.90 USD (-4.07%)
收盘价
最后更新: 2026年10月1日
1.15B USD
市值
股价为何变动
截至 2026年10月1日，ATEC 下跌 4.07%，收于 $9.90。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Spine-Focused Medical Technology Company
Alphatec Holdings, operating as ATEC, develops technologies intended to improve the planning and execution of spine surgery. Its product ecosystem combines implants, biologics, imaging, surgical navigation, neuromonitoring, and procedural techniques.
Procedural Innovation
ATEC develops procedure-specific systems for lateral, posterior, deformity, and other spine approaches. Techniques such as prone transpsoas surgery are supported by integrated instruments, implants, imaging, and intraoperative information intended to make complex procedures more reproducible.
InformatiX Platform
The InformatiX platform brings together EOS imaging, surgical planning, navigation, robotics, and data analytics. It is designed to support decisions before and during surgery and to connect the company's hardware with imaging and clinical information.
SafeOp Neuromonitoring
SafeOp provides automated nerve monitoring and surgical information during spine procedures. Integration with ATEC's procedural systems is intended to help surgeons understand patient anatomy and neural risk while operating.
Implant and Biologics Portfolio
ATEC sells spinal implants, fixation systems, interbody devices, and biologic products used in fusion procedures. The company develops these products as part of complete procedural solutions rather than as stand-alone implants, creating cross-selling opportunities within surgeon accounts.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。